Despite the short development time of the first COVID19 vaccines, vaccine candidates go through a long journey before they finally reach the people they are supposed to protect. An active role is played by GBA Group Pharma and its 4 subsidiaries: Pharmacelsus, LKF Central Lab, GBA Pharma Labs and ABF. They mastered many challenges related with the pandemic and handle essential steps of a vaccine development and logistics: From R&D through production and approval to release and distribution. Read how the four companies work together synergistically to ensure the quality of vaccines and drugs at page 103 of the latest transkript issue (in German): https://lnkd.in/eEUaDmd